Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/01/22
End: 04/30/31
Due: 04/30/32
Phase: N/A
Priority: Normal
Start: 04/18/22
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 03/18/25
End: 01/31/27
Due: 01/31/28
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML) | NCT05183035 | LLS PedAL Initiative, LLC | user2@example.com | None | 2022-10-01 | 2031-04-30 | 2032-04-30 | - | - | 2025-07-14 |
| The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study | NCT04726241 | LLS PedAL Initiative, LLC | user2@example.com | None | 2022-04-18 | 2028-12-31 | 2029-12-31 | - | - | 2025-07-14 |
| Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia | NCT06376162 | LLS PedAL Initiative, LLC | user2@example.com | None | 2025-03-18 | 2027-01-31 | 2028-01-31 | - | - | 2025-07-14 |